Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Howe Sound Research | PRODUCT CODE: 1309752

Cover Image

PUBLISHER: Howe Sound Research | PRODUCT CODE: 1309752

Single Cell Genomics Markets. Forecasts by Technology, Product, Workflow, User and Country. With Executive and Consultant Guides. 2023 to 2027

PUBLISHED:
PAGES: 335 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 6995
PDF (Five User License)
USD 10495
PDF (Enterprise License)
USD 13995

Add to Cart

OVERVIEW:

Will Single Cell Genomics replace traditional genomics? The sky just might be the limit on this new approach to capturing genetic information. Find out all about it in this new report.

Single Cell Genomics is emerging as a mainstay of scientific research and development. New life forms have already been identified. This means new diseases and new cures. There are applications in every aspect of healthcare. SGC is just coming out of the lab. It is finding its footing in new clinical applications especially related to immune-oncology and microbiology. The market is booming as understanding the genomics of individual cells opens up a whole new world of biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Situation Analysis
  • 1.2 Guide for Executives and Marketing Staff
  • 1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

  • 2.1 What is Single Cell Genomics?
  • 2.2 SCG - Still Early Days
  • 2.3 Market Definition
    • 2.3.1 Market Size
    • 2.3.2 Currency
    • 2.3.3 Years
  • 2.4 Methodology
    • 2.4.1 Methodology
    • 2.4.2 Sources
    • 2.4.3 Authors
  • 2.5 Sizing the Genome - Not What You Think
    • 2.5.1 Cost, Price and Genome Size, Pricing Practice
  • 2.6 GLOBAL LISTING OF HIGH THROUGHPUT SEQUENCING ESTABLISHMENTS INSTALLED BASE
  • - Location & Contacts

3 Single Cell Genomics - Guide to Technology

  • 3.1 Isolating Single Cells
    • 3.1.1 FACS
    • 3.1.2 LCM
    • 3.1.3 Micromanipulators
    • 3.1.4 Microfluidics
  • 3.2 Amplification
    • 3.2.1 WTA - Whole Transcriptome Amplification
    • 3.2.2 WGA - Whole Genome Amplification
  • 3.3 PCR
  • 3.4 NGS
  • 3.5 Microarray
  • 3.6 Digital Spatial Profiling (DSP) Technology

4 Industry Overview

  • 4.1 Players in a Dynamic Market
    • 4.1.1 Academic Research Lab
    • 4.1.2 Diagnostic Test Developer
    • 4.1.3 Instrumentation Supplier
    • 4.1.4 Chemical/Reagent Supplier
    • 4.1.5 Pathology Supplier
    • 4.1.6 Independent Clinical Laboratory
    • 4.1.7 Public National/regional Laboratory
    • 4.1.8 Hospital Laboratory
    • 4.1.9 Physicians Office Lab (POLS)
    • 4.1.10 Audit Body
    • 4.1.11 Certification Body

5 Market Trends

  • 5.1 Factors Driving Growth
    • 5.1.1 Immuno-oncology
    • 5.1.2 Research Range
    • 5.1.3 Technology Maturity & Convergence
    • 5.1.4 Declining Costs
  • 5.2 Factors Limiting Growth
    • 5.2.1 Competition
    • 5.2.2 Instrument Integration
    • 5.2.3 Technology Shift
    • 5.2.4 Technology Limitations
  • 5.3 Technology Development
    • 5.3.1 Spatial Profiling
    • 5.3.2 Integration
    • 5.3.3 Big Data
    • 5.3.4 Kits and Commodities
  • 5.4 Instrumentation, Automation and Diagnostic Trends
    • 5.4.1 Traditional Automation and Centralization
    • 5.4.2 The New Automation, Decentralization and Point Of Care
    • 5.4.3 Instruments Key to Market Share
    • 5.4.4 Bioinformatics Plays a Role
    • 5.4.5 PCR Takes Command
    • 5.4.6 Next Generation Sequencing Fuels a Revolution
    • 5.4.7 NGS Impact on Pricing
    • 5.4.8 Whole Genome Sequencing, A Brave New World
    • 5.4.9 Companion Diagnostics Blurs Diagnosis and Treatment
    • 5.4.10 Shifting Role of Diagnostics

6 Single Cell Genomics Recent Developments

  • 6.1 Recent Developments - Importance and How to Use This Section
    • 6.1.1 Importance of These Developments
    • 6.1.2 How to Use This Section
  • 6.2 MGI and Xpress Genomics to Advance Single-cell RNA-Sequencing
  • 6.3 Single-Cell Sequencing Reveals Traits in Cereal Crops
  • 6.4 Single-cell Genomics meets Human Genetics
  • 6.5 Singular Genomics Launches Kits for Single Cell Sequencing
  • 6.6 Scale Biosciences Introduces Disruptive Single-Cell Profiling Solutions
  • 6.7 Singleron showcases latest single cell sequencing technology
  • 6.8 Oxford Nanopore to Make Single-cell Sequencing Accessible to Any Laboratory
  • 6.9 Single-Cell RNA-seq Method Enables Profiling Live Cells
  • 6.10 Novogene Launches New Single-Cell Lab
  • 6.11 New DNA Atlas Provides Clues for Heart Disease Risk
  • 6.12 BioSkryb Genomics Launches ResolveOME
  • 6.13 Parse Biosciences Expands Single-Cell Product Line
  • 6.14 Massively Multiplexed Single-Cell In Situ Spatial Genomics Now in U.S. Market
  • 6.15 Pfizer Centralizes Single Cell Data on Seven Bridges System
  • 6.16 Consortium to Standardize Single-Cell Sequencing
  • 6.17 Scienion, Cellenion Enter Licensing Deal
  • 6.18 Immunai Acquires Swiss Bioinformatics Firm Nebion
  • 6.19 Startup MiCareo Targets Rare Cell Isolation Market
  • 6.20 Parse Biosciences Lowers Cost Barriers to Single-Cell Transcriptomics
  • 6.21 Deepcell Advancing Tech for Single-Cell Genomics
  • 6.22 10x Genomics Outlines 2021 Growth Plans
  • 6.23 Single-Cell Genomics Firm Analytical Biosciences Inks Deal with BioMap
  • 6.24 IsoPlexis Features Cheaper, More Flexible Single-Cell Proteomic Systems
  • 6.25 DNTR-Seq Combines WGS, Transcriptomics in Single Cells
  • 6.26 BitBiome Builds Single-Cell Bacterial Sequencing Business
  • 6.27 S2 Genomics Signs Distribution Agreements for Asia-Pacific
  • 6.28 Single-Cell COVID-19 Study Investigates Immune Hyperactivation
  • 6.29 Levitas Bio to Launch Magnetic Levitation Cell Separation Platform
  • 6.30 Single-Cell and Spatial Genomics
  • 6.31 Single-Cell Genomics
  • 6.32 Namocell, Takara Bio, HepaTx Partner on Single-Cell Genomics
  • 6.33 Vizgen Launches With $14M Series A Financing
  • 6.34 SeqWell Raises $9M in Series B Round

7 Profiles of Key Single Cell Genomics Companies

  • 7.1 10x Genomics, Inc.
  • 7.2 1CellBio
  • 7.3 Agilent/Dako
  • 7.4 Beckman Coulter Diagnostics
  • 7.5 Becton, Dickinson and Company
  • 7.6 Berkley Lights
  • 7.7 BGI Genomics Co. Ltd
  • 7.8 BioGenex
  • 7.9 Bio-Rad Laboratories, Inc.
  • 7.10 BioSkryb Genomics
  • 7.11 Bitbiome
  • 7.12 Bruker
  • 7.13 Cell Microsystems
  • 7.14 Cellsee Diagnostics
  • 7.15 CellSorter
  • 7.16 Cytek Biosciences
  • 7.17 Cytena
  • 7.18 Deepcell
  • 7.19 Dolomite Bio
  • 7.20 Element Biosciences
  • 7.21 Element Biosciences
  • 7.22 Epic Sciences
  • 7.23 Fluxion Biosciences
  • 7.24 Illumina
  • 7.25 Incell Dx
  • 7.26 Labcyte
  • 7.27 Leica Biosystems
  • 7.28 Menarini Silicon Biosystems
  • 7.29 Miltenyi Biotec
  • 7.30 Mission Bio
  • 7.31 Myllia Biotechnology
  • 7.32 Nanostring
  • 7.33 New England Biolabs, Inc.
  • 7.34 Novogene Bioinformatics Technology Co., Ltd.
  • 7.35 Oxford Nanopore Technologies
  • 7.36 Pacific Biosciences
  • 7.37 Parse Biosciences
  • 7.38 Qiagen
  • 7.39 Readcoor
  • 7.40 Revvity
  • 7.41 Roche Molecular Diagnostics
  • 7.42 S2 Genomics
  • 7.43 Scale Biosciences
  • 7.44 Singleron Biotechnologies
  • 7.45 Singular Genomics
  • 7.46 Singulomics
  • 7.47 Sony Biotechnology
  • 7.48 Standard BioTools
  • 7.49 Takara Bio
  • 7.50 Thermo Fisher Scientific Inc.
  • 7.51 Ultima Genomics
  • 7.52 Vizgen
  • 7.53 Watchmaker Genomics

8 Single Cell Genomics Global Market Size

  • 8.1 Global Market Overview by Country
    • 8.1.1 Table - Global Market by Country
    • 8.1.2 Chart - Global Market by Country
  • 8.2 Global Market Size by Technology - Overview
    • 8.2.1 Table - Global Market by Technology
    • 8.2.2 Chart - Global Market by Technology - Base/Final Year Comparison
    • 8.2.3 Chart - Global Market by Technology - Base Year
    • 8.2.4 Chart - Global Market by Technology - Final Year
    • 8.2.5 Chart - Global Market by Technology - Share by Year
    • 8.2.6 Chart - Global Market by Technology - Segment Growth
  • 8.3 Global Market by Product - Overview
    • 8.3.1 Table - Global Market by Product
    • 8.3.2 Chart - Global Market by Product - Base/Final Year Comparison
    • 8.3.3 Chart - Global Market by Product - Base Year
    • 8.3.4 Chart - Global Market by Product - Final Year
    • 8.3.5 Chart - Global Market by Product - Share by Year
    • 8.3.6 Chart - Global Market by Product - Segment Growth
  • 8.4 Global Market by Workflow - Overview
    • 8.4.1 Table - Global Market by Workflow
    • 8.4.2 Chart - Global Market by Workflow - Base/Final Year Comparison
    • 8.4.3 Chart - Global Market by Workflow - Base Year
    • 8.4.4 Chart - Global Market by Workflow - Final Year
    • 8.4.5 Chart - Global Market by Workflow - Share by Year
    • 8.4.6 Chart - Global Market by Workflow - Segment Growth
  • 8.5 Global Market by End User - Overview
    • 8.5.1 Table - Global Market by End User
    • 8.5.2 Chart - Global Market by End User - Base/Final Year Comparison
    • 8.5.3 Chart - Global Market by End User - Base Year
    • 8.5.4 Chart - Global Market by End User - Final Year
    • 8.5.5 Chart - Global Market by End User - Share by Year
    • 8.5.6 Chart - Global Market by End User - Segment Growth

9 Global Market by Technology

  • 9.1 PCR Market
    • 9.1.1 Table - PCR Market by Country
    • 9.1.2 Chart - PCR Market by Country
  • 9.2 qPCR Market
    • 9.2.1 Table - qPCR Market by Country
    • 9.2.2 Chart - qPCR Market Growth
  • 9.3 NGS Market
    • 9.3.1 Table - NGS Market by Country
    • 9.3.2 Chart - NGS Market Growth
  • 9.4 Microarray Market
    • 9.4.1 Table - Microarray Market by Country
    • 9.4.2 Chart - Microarray Market Growth
  • 9.5 Other Technology Market
    • 9.5.1 Table - Other Technology Market by Country
    • 9.5.2 Chart - Other Technology Market Growth

10 Single Cell Genomics Market by Product

  • 10.1 Instrument Market
    • 10.1.1 Table - Instrument Market by Country
    • 10.1.2 Chart - Instrument Market Growth
  • 10.2 Reagent Market
    • 10.2.1 Table - Reagent Market by Country
    • 10.2.2 Chart - Reagent Market Growth
  • 10.3 Software & Other Market
    • 10.3.1 Table - Software & Other Market by Country
    • 10.3.2 Chart - Software & Other Market Growth

11 Single Cell Genomics Market by Workflow

  • 11.1 Cell Isolation Market
    • 11.1.1 Table - Cell Isolation Market by Country
    • 11.1.2 Chart - Cell Isolation Market Growth
  • 11.2 Sample Preparation Market
    • 11.2.1 Table - Sample Preparation Market by Country
    • 11.2.2 Chart - Sample Preparation Market Growth
  • 11.3 Genomic Analysis Market
    • 11.3.1 Table - Genomic Analysis Market by Country
    • 11.3.2 Chart - Genomic Analysis Market Growth

12 Single Cell Genomics Market by End User

  • 12.1 Research Market
    • 12.1.1 Table - Research Market by Country
    • 12.1.2 Chart - Research Market Growth
  • 12.2 BioPharma Market
    • 12.2.1 Table - BioPharma Market by Country
    • 12.2.2 Chart - BioPharma Market Growth
  • 12.3 Clinical Market
    • 12.3.1 Table - Clinical Market by Country
    • 12.3.2 Chart - Clinical Market Growth
  • 12.4 Other End User Market
    • 12.4.1 Table - Other End User Market by Country
    • 12.4.2 Chart - Other End User Market Growth

13 Appendices

  • 13.1 FDA Cancer Drug Approvals by Year
  • 13.2 Clinical Trials Started Historical
  • 13.3 Prevalence of Cancer Treatments

Table of Tables

  • Table 1 Global List of Gene Sequencing Facilities
  • Table 2 Cell Isolation Overview
  • Table 3 Market Players by Type
  • Table 4 Five Factors Driving Growth
  • Table 5 Three Factors Limiting Growth
  • Table 6 Seven Key Diagnostic Laboratory Technology Trends
  • Table 7 Single Cell Genomics Global Market by Country/Region
  • Table 8 Single Cell Genomics Global Market by Technology
  • Table 9 Global Market by Product
  • Table 10 Global Market by Workflow
  • Table 11 Global Market by End User
  • Table 12 PCR Market by Country
  • Table 13 qPCR Market by Country
  • Table 14 NGS Market by Country
  • Table 15 Microarray Market by Country
  • Table 16 Other Technology Market by Country
  • Table 17 Instrument Market by Country
  • Table 18 Reagent Market by Country
  • Table 19 Software & Other Market by Country
  • Table 20 Cell Isolation Market by Country
  • Table 21 Sample Preparation Market by Country
  • Table 22 Genomic Analysis Market by Country
  • Table 23 Research Market by Country
  • Table 24 BioPharma Market by Country
  • Table 25 Clinical Market by Country
  • Table 26 Other End User Market by Country

Table of Figures

  • Figure 1 Size of Different Genomes
  • Figure 2 flourescence Activated Sorter
  • Figure 3 The Road to Diagnostics
  • Figure 4 Centralized vs. Decentralized Laboratory Service
  • Figure 5 A Highly Multiplexed Syndromic Testing Unit
  • Figure 6 The Real Cost to Sequence the Human Genome
  • Figure 7 The Codevelopment Process
  • Figure 8 Comparing MDx Diagnostic and Traditional Testing
  • Figure 9 Market Size by Country
  • Figure 10 Global Market by Technology - Base vs. Final Year
  • Figure 11 Technology Market Base Year
  • Figure 12 Technology Market Final Year
  • Figure 13 Technology Share by Year
  • Figure 14 Technology Segment Growth
  • Figure 15 Product - Base vs. Final Year
  • Figure 16 Product Market Base Year
  • Figure 17 Product Market Final Year
  • Figure 18 Product Share by Year
  • Figure 19 Product Segment Growth
  • Figure 20 Workflow - Base vs. Final Year
  • Figure 21 Workflow Market Base Year
  • Figure 22 Workflow Market Final Year
  • Figure 23 Workflow Share by Year
  • Figure 24 Workflow Segment Growth
  • Figure 25 End User - Base vs. Final Year
  • Figure 26 End User Market Base Year
  • Figure 27 End User Market Final Year
  • Figure 28 End User Share by Year
  • Figure 29 End User Segment Growth
  • Figure 30 Chart - PCR Market Growth
  • Figure 31 Chart qPCR Market Growth
  • Figure 32 Chart - NGS Market Growth
  • Figure 33 Chart - Microarray Market Growth
  • Figure 34 Chart - Other Technology Market Growth
  • Figure 35 Chart - Instrument Market Growth
  • Figure 36 Chart - Reagent Market Growth
  • Figure 37 Chart - Software & Other Market Growth
  • Figure 38 Chart - Cell Isolation Market Growth
  • Figure 39 Chart - Sample Preparation Market Growth
  • Figure 40 Chart - Genomic Analysis Market Growth
  • Figure 41 Chart - Research Market Growth
  • Figure 42 Chart - BioPharma Market Growth
  • Figure 43 Chart - Clinical Market Growth
  • Figure 44 Chart - Other End User Market Growth
  • Figure 45 FDA Cancer Drug Approvals by Year
  • Figure 46 Clinical Trials for Immunotherapy by Year
  • Figure 47 Pie Chart of Prevalence of Cancer Treatments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!